Compare BTMD & DFNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BTMD | DFNS |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | United States |
| Employees | N/A | 15 |
| Industry | Medicinal Chemicals and Botanical Products | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.4M | 67.1M |
| IPO Year | 2021 | N/A |
| Metric | BTMD | DFNS |
|---|---|---|
| Price | $2.09 | $1.92 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 138.6K | ★ 749.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $197,191,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.37 | N/A |
| P/E Ratio | $3.12 | ★ N/A |
| Revenue Growth | ★ 6.38 | N/A |
| 52 Week Low | $2.02 | $1.77 |
| 52 Week High | $4.75 | $2.44 |
| Indicator | BTMD | DFNS |
|---|---|---|
| Relative Strength Index (RSI) | 43.18 | 48.64 |
| Support Level | $2.02 | N/A |
| Resistance Level | $2.37 | $2.44 |
| Average True Range (ATR) | 0.10 | 0.27 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 33.33 | 14.29 |
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.
T3 Defense Inc is a world-wide aerospace and defense federated holding company focused on acquiring and operating mission-critical defense businesses embedded at critical chokepoints of long-cycle national security programs. Through disciplined M&A, centralized capital and ideas, and decentralized operating autonomy, it aims to build an asymmetric edge by strengthening critical defense capabilities and compounding long-term value.